MedPath

The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice

Conditions
The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice
Interventions
Other: antibiotic
Registration Number
NCT04620577
Lead Sponsor
Xian-Jun Yu
Brief Summary

To investigate the influence of antibiotics on the incidence of biliary tract infections after PTCD for malignant obstructive jaundice.

Detailed Description

This project designed a large-scale, single-center, prospective randomized controlled clinical trial to explore the impact of antibiotics on the incidence of biliary tract infections after PTCD with malignant obstructive jaundice. This study will provide evidence-based medical evidence for the need for routine use of antibiotics to prevent biliary tract infections after PTCD with malignant obstructive jaundice, and provide references for clinicians to prevent patients from PTCD infections.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  1. 18-80 years old;
  2. ECOG score 0-1 before operation;
  3. Patients diagnosed as pancreatic head cancer and periampullary cancer according to preoperative imaging, including ampullary cancer, extrahepatic bile duct cancer and duodenal papillary cancer;
  4. Bilirubin>200 mmol/L before PTCD , and the duration of PTCD continuous drainage >2 weeks;
  5. Volunteer to participate and sign the informed consent form;
Exclusion Criteria
  1. Decompensated liver cirrhosis, acute and chronic hepatitis and other diseases before surgery;
  2. A history of other malignant tumors before surgery;
  3. Duration of preoperative PTCD drainage<2 weeks;
  4. Jaundice caused by other reasons besides cancer around the ampulla and cancer of the head of the pancreas;

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Antibiotic groupantibioticInfusion of ceftriaxone sodium needle (2g, solvent 100ml normal saline) within 1h before and 12h after PTCD.
No-antibiotic groupantibioticInfusion of Normal saline within 1h before and 12h after PTCD.
Primary Outcome Measures
NameTimeMethod
Incidence of patients with biliary tract infection after surgeryOctober 2020 to June 2023

Incidence of patients with biliary tract infection after surgery

Secondary Outcome Measures
NameTimeMethod
Decline rate of bilirubin in patients after PTCDOctober 2020 to June 2023

Decline rate of bilirubin in patients after PTCD

Trial Locations

Locations (1)

Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath